Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · IEX Real-Time Price · USD

2.450

-0.120 (-4.67%)

At close: Jul 19, 2024, 4:00 PM

2.470

+0.020 (0.82%)

Pre-market: Jul 22, 2024, 8:54 AM EDT

Vivos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Market Capitalization	8	15	9	52	103	-	Upgrade
Market Cap Growth	30.31%	61.00%	-82.13%	-49.94%	-	-	Upgrade
Enterprise Value	8	15	8	29	86	3	Upgrade
PE Ratio	-	-1.10	-0.39	-2.55	-5.75	-	Upgrade
PS Ratio	0.62	1.08	0.58	3.07	7.92	-	Upgrade
PB Ratio	14.30	36.24	1.93	2.03	6.11	-	Upgrade
P/FCF Ratio	-1.13	-1.16	-0.45	-2.86	-17.83	-	Upgrade
P/OCF Ratio	-1.21	-1.25	-0.47	-3.29	-18.21	-	Upgrade
EV/Sales Ratio	0.57	1.10	0.51	1.72	6.61	0.26	Upgrade
EV/EBITDA Ratio	-0.83	-1.18	-0.35	-1.48	-7.69	-0.30	Upgrade
EV/EBIT Ratio	-0.80	-1.12	-0.34	-1.43	-7.23	-0.28	Upgrade
EV/FCF Ratio	-1.07	-1.19	-0.40	-1.60	-14.90	-0.54	Upgrade
Debt / Equity Ratio	3.23	4.85	0.50	0.05	0.08	-1.26	Upgrade
Debt / EBITDA Ratio	-0.13	-0.15	-0.10	-0.06	-0.11	-0.38	Upgrade
Debt / FCF Ratio	-0.16	-0.16	-0.12	-0.07	-0.22	-0.67	Upgrade
Quick Ratio	0.39	0.25	0.58	3.43	2.52	0.19	Upgrade
Current Ratio	0.45	0.34	0.80	3.64	2.60	0.22	Upgrade
Asset Turnover	1.15	1.06	0.75	0.47	0.80	1.45	Upgrade
Interest Coverage	-	-	-	-1448.14	-124.59	-77.00	Upgrade
Return on Equity (ROE)	-1989.60%	-568.60%	-188.70%	-74.60%	-257.50%	-1248.00%	Upgrade
Return on Assets (ROA)	-134.30%	-104.70%	-110.80%	-56.80%	-109.40%	-149.20%	Upgrade
Return on Capital (ROIC)	-646.51%	-718.87%	-346.98%	-76.04%	-66.13%	-1379.98%	Upgrade
Earnings Yield	-187.97%	-91.20%	-257.76%	-39.18%	-17.39%	-	Upgrade
FCF Yield	-139.84%	-85.93%	-221.72%	-35.02%	-5.61%	-	Upgrade
Buyback Yield / Dilution	-132.99%	-32.46%	-8.39%	-65.00%	-4.36%	-6.78%	Upgrade
Total Shareholder Return	-132.99%	-32.46%	-8.39%	-65.00%	-4.36%	-6.78%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).